Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 77.00 | |
10 mg | In stock | $ 106.00 | |
25 mg | In stock | $ 169.00 | |
50 mg | In stock | $ 247.00 | |
100 mg | In stock | $ 364.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 91.00 |
Description | BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. |
Targets&IC50 | FLT3:3.5 μM, RSK3:1.2 μM, CDK5-p35:6.5 μM, Pim1:3.7 μM, DRAK1:2.8 μM, PKG1α:6.5 μM, SGK:13.8 μM, RSK2:2.4 μM, RSK1:1.5 μM |
In vitro | BRD7389 (1 μM) almost completely blocked Carbachol (1 mM)-stimulated cell proliferation, but has little effect on the basal level of proliferation[1]. BRD7389 (0.425, 0.85, 1.7, 3.4, 6.8 μM) induces insulin expression in mouse α-cells and induces a dose-dependent up-regulation of insulin (Ins2) mRNA, peaking at 0.85 μM. BRD7389 increases β-cell-specific gene expression in primary human islet cells. BRD7389 (0.85-6.8μM) significantly up-regulates Pdx1 mRNA expression in mouse α-cell line[2]. |
Molecular Weight | 366.41 |
Formula | C24H18N2O2 |
CAS No. | 376382-11-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (54.58 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BRD7389 376382-11-5 Angiogenesis Apoptosis Cell Cycle/Checkpoint Chromatin/Epigenetic JAK/STAT signaling MAPK Metabolism PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors CDK DAPK S6 Kinase FLT Pim SGK cancer S6K Inhibitor colon BRD 7389 inhibit RSK islets diabetes pancreatic SNU-407 BRD-7389 Ribosomal S6 Kinase (RSK) inhibitor